RECENT NEWS

Aiforia Technologies, a leading Finnish provider of deep learning AI solutions for digital pathology, has entered into a local agreement with Siemens Healthineers Finland. The partnership focuses on joint co-marketing and sales efforts, leveraging Siemens Healthineers Finland’s strong regional network and expertise in healthcare technology.

CPI has published the latest reports from its MedTech Accelerator: Rapid Regulatory Support (MARRS) fund programme. Building on previous research, the reports show how stronger collaboration across industry, government, academia, and the NHS can unlock the potential of key UK MedTech sectors and accelerate innovation for the benefit of patients.

Catch up with the October issue of Pathology in Practice, now available to read online.

Bruker has announced FDA clearance for its MALDI Biotyper CA System, marking a significant advancement in clinical microbial identification capabilities.

AnalytiChem UK (formerly Cherwell), cleanroom microbiology solutions expert, has appointed Tom Pickford as Business Development Manager for the Midlands. This is a new role created within the recently renamed company to enhance collaboration and support for both new and existing customers across this central region of the UK.

Sinagapore-based researchers have uncovered a surprising mechanism showing how mosquito saliva can alter the human body’s immune response during chikungunya virus (CHIKV) infection, contributing to the country’s broader efforts to strengthen infectious disease preparedness.

Research from the University of Gothenburg, Sweden, clarifies the complex interaction between gut bacteria and irritable bowel syndrome. Experiments demonstrate that gut bacteria can produce the important substance serotonin. The finding may lead to new future treatments.

Whole-genome sequencing (WGS) offered to breast cancer patients is likely to identify unique genetic features that could either guide immediate treatment or help match patients to clinical trials for over 15,000 women a year, say researchers at the University of Cambridge.

Roche presented major updates on its innovative sequencing by expansion (SBX) technology at the American Society of Human Genetics (ASHG) 2025 Annual Meeting in Boston, USA recently.

PathAI has announced the latest update to AISight DX, its cloud-based digital pathology image management system, which now benefits from new capabilities for tumour board presentations, consult workflows, and voice-enabled reporting.

Lab Innovations, the UK’s largest trade show for the laboratory industry, taking place at the NEC, Birmingham, on 29-30 October, has announced its most exciting conference programme yet.

With NHS pathology services preparing for winter pressures and a rise in respiratory infections, a new partnership between Copan and Sterilab is making it easier for microbiology departments to access premium-quality swabs proven to support diagnostic accuracy and laboratory efficiency in high-turnover environments.

Proscia will add AI biomarker detection for skin tissue to its Concentriq software platform. Powered by Primaa, Cleo Skin will strengthen Concentriq’s lead in offering the industry’s broadest portfolio of AI solutions on a single platform.

Artificial intelligence (AI) tools that could transform patient care – from reducing bowel cancer test times from weeks to minutes, to detecting skin cancer and genetic eye diseases sooner – are being tested in the next phase of the Medicines and Healthcare products Regulatory Agency’s (MHRA) AI Airlock programme.

The National Institute for Health and Care Research (NIHR) has added a new Translational Research Collaboration in Infection and Antimicrobial Resistance (AMR) to its portfolio.

Leading Alzheimer's disease experts at this year's Alzheimer Europe Conference, in partnership with Eli Lilly and Company, have called for urgent improvements to diagnostic pathways to ensure people in Europe can benefit from new therapeutic innovation.

A study carried out by a team of researchers from The Institute of Cancer Research has identified a more accurate way of predicting which multiple myeloma patients are likely to relapse early following treatment.

The US Food and Drug Administration (FDA) has granted 510(k) clearance for Hologic’s Panther Fusion Gastrointestinal (GI) Bacterial and Expanded Bacterial Assays. The assays also now have CE marking in the European Union in accordance with the In Vitro Diagnostic Regulation (IVDR).

Precision proteomics firm Alamar Biosciences has announced the launch of the NULISAqpcr BD-pTau217 Assay, which it says is a transformative leap in blood-based quantification of brain-derived phosphorylated tau 217 (pTau217)—a pivotal biomarker in Alzheimer's disease research and other tauopathies.

Bio-Techne Corporation has announced a significant enhancement to its agreement with Oxford Nanopore Technologies, broadening Bio-Techne's ability to develop a portfolio of genetic products on Oxford Nanopore Technologies platforms and extending the collaboration.